Taro Teshima

Low hemoglobin and PSA kinetics are prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients

Yuji Hakozaki, Yuta Yamada, Yuta Takeshima et al. · Scientific Reports · 2023 · 42 citations · Full text

Medicine, Oncology, Pathology +17

Comparison of perioperative outcomes in elderly (age ≧ 75 years) vs. younger men undergoing robot-assisted radical prostatectomy

Yuta Yamada, Taro Teshima, Tetsuya Fujimura et al. · PLoS ONE · 2020 · 39 citations · Full text

Medicine, Perioperative Medicine, Surgery +17

Carbon 11-choline positron emission tomography/computed tomography and palliative local therapy for castration-resistant prostate cancer

Keina Nozaki, Taketo Kawai, Tetsuya Fujimura et al. · International Urology and Nephrology · 2019 · 21 citations

Medicine, Nuclear Medicine, Oncology +16

Different immunological effects of the molecular targeted agents sunitinib, everolimus and temsirolimus in patients with renal cell carcinoma

Yukari Kobayashi, Daisuke Yamada, Taketo Kawai et al. · International Journal of Oncology · 2020 · 13 citations · Full text

Medicine, Immunology, Pharmacology +17

Clinical significance and risk factors of International Society of Urological Pathology (ISUP) grade upgrading in prostate cancer patients undergoing robot-assisted radical prostatectomy

Yuta Takeshima, Yuta Yamada, Taro Teshima et al. · BMC Cancer · 2021 · 13 citations · Full text

Medicine, Pathology, Surgery +16